Abraham Ceesay
CIK 1722140 · Chief Executive Officer · last filed 2026-07-15
Abraham Ceesay is a Chief Executive Officer who has filed 36 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing shows the insider sold $328.4K of RAPP on Jul 15, 2026. Across all open-market trades the lifetime net is −$7.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $26.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$26.90M
6
36
-$7.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Chief Executive Officer | 621,546 | $41.96 | $26.08M | -$4.15M | 11 | 2026-07-15 |
| CRL | Director | 2,384 | $240.43 | $573.2K | $0 | 2 | 2026-05-11 |
| PCRX | Director | 9,039 | $26.81 | $242.3K | -$64.0K | 4 | 2025-09-08 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | President | 19,210 | $44.96 | $863.7K | -$3.26M | 6 | 2023-02-08 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | President | — | $18.07 | — | $0 | 1 | 2021-06-03 |
| scPharmaceuticals Inc. (SCPH) Delisted | Chief Operating Officer | — | $5.67 | — | $0 | 1 | 2018-01-19 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-15 | RAPP | Sell (S) | −8,210 | -$328.4K | EDGAR |
| 2026-07-01 | RAPP | Sell (S) | −8,220 | -$327.4K | EDGAR |
| 2026-06-29 | RAPP | Notice (144) | −99,480 | -$4.02M | EDGAR |
| 2026-06-12 | PCRX | Notice (144) | −9,039 | -$210.4K | EDGAR |
| 2026-05-11 | CRL | Grant (A) | +1,438 | $255.4K | EDGAR |
| 2026-02-19 | RAPP | Sell (S) | −10,916 | -$320.4K | EDGAR |
| 2026-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2026-01-22 | RAPP | Sell (S) | −10,916 | -$285.1K | EDGAR |
| 2025-12-18 | RAPP | Sell (S) | −10,916 | -$323.5K | EDGAR |
| 2025-12-17 | RAPP | Notice (144) | −15,249 | -$469.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.